Citigroup
NUTX

Citigroup’s Nutex Health NUTX Stock Holding History

Citigroup’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Buy
2,592
+1,905
+277% +$241K ﹤0.01% 3962
2026
Q1 		$65.3K Buy
687
+412
+150% +$50.5K ﹤0.01% 4426
2025
Q4 		$45.3K Sell
275
-93
-25% -$12.3K ﹤0.01% 4602
2025
Q3 		$38K Sell
368
-1,046
-74% -$103K ﹤0.01% 4573
2025
Q2 		$176K Sell
1,414
-710
-33% -$91.7K ﹤0.01% 4132
2025
Q1 		$99.9K Sell
2,124
-5,762
-73% -$281K ﹤0.01% 4601
2024
Q4 		$250K Buy
7,886
+5,488
+229% +$156K ﹤0.01% 4274
2024
Q3 		$52K Buy
+2,398
New +$34.6K ﹤0.01% 5012
2024
Q2 		– Sell
-5
Closed -$65 – 5718
2024
Q1 		$65 Hold
5
– – ﹤0.01% 5512
2023
Q4 		$127 Hold
5
– – ﹤0.01% 5551
2023
Q3 		$142 Sell
5
-56
-92% -$2.7K ﹤0.01% 5363
2023
Q2 		$3.83K Buy
61
+7
+13% +$600 ﹤0.01% 5213
2023
Q1 		$8.24K Sell
54
-11
-17% -$2.23K ﹤0.01% 4812
2022
Q4 		$18.6K Buy
65
+61
+1,525% +$11.7K ﹤0.01% 4625
2022
Q3 		$1K Sell
4
-10
-71% -$4.24K ﹤0.01% 5657
2022
Q2 		$7K Buy
+14
New +$16.5K ﹤0.01% 5505

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Citigroup's NUTX Position: Q2 2026 in Review

Citigroup increased its Nutex Health (NUTX) stake by 277% in Q2 2026, buying an estimated $241K and bringing the position to 2,592 shares worth $443K. The position accounts for ﹤0.01% of the portfolio, ranked #3962.

Citigroup first reported a position in NUTX in Q2 2022 and has held it in 16 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Citigroup held 2,592 shares of Nutex Health worth $443K as of Q2 2026.
  • Citigroup bought 1,905 Nutex Health shares in Q2 2026, an estimated $241K.
  • Nutex Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3962 holding.
  • Citigroup first reported a position in Nutex Health in Q2 2022 and has held it in 16 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.